Is this a real eligibility check or just a quiz?

Both. The calculator applies the actual FDA weight-management criteria a physician would use — BMI ≥30, or BMI ≥27 with a qualifying condition. Educational screening only; final eligibility determination rests with a licensed clinician.

Is my health information safe? What do you actually store?

Medical answers are never written to our database — they live in memory only long enough to generate the personalized report. Only name, email, and phone are stored, exclusively for report delivery and the educational follow-up emails. No data sale, one-click unsubscribe.

What does GLP-1 therapy actually mean?

GLP-1 medications (semaglutide, tirzepatide, sold as Wegovy, Zepbound, Ozempic, Mounjaro) mimic a hormone produced after meals. They reduce appetite, slow gastric emptying, and improve insulin response. In trials they produced 15–22% average body weight loss over 14–18 months.

No. Insurance can sometimes cover branded options like Wegovy or Zepbound, but cash-pay and licensed compounded options exist for $150–$650/month. The free report walks through realistic options for your situation.

What if my BMI is below 30?

Many people qualify with BMI 27–29.9 if they also have a weight-related condition (prediabetes, hypertension, sleep apnea, fatty liver, PCOS, T2D, high cholesterol, or cardiovascular disease). The calculator accounts for this. If below all thresholds, the report says so honestly.

How long does this take?

About 90 seconds for the calculator, instant on-screen results, and the report email arrives in under a minute.

For appropriate candidates under physician supervision, yes — extensively studied (STEP, SURMOUNT trials). Most common side effects are GI. Real contraindications exist (medullary thyroid carcinoma, MEN2, severe pancreatitis). Physician evaluation is how you know if it's safe for you specifically.

CheckMyGLP — Free GLP-1 Eligibility Calculator

Find out if you qualify for GLP-1 in 90 seconds — free.

CheckMyGLP applies the same FDA weight-management criteria a physician would use:

BMI ≥30 — qualifies on BMI alone
BMI ≥27 with a weight-related comorbidity (Type 2 diabetes, prediabetes, hypertension, sleep apnea, fatty liver, high cholesterol, cardiovascular disease, PCOS) — qualifies on BMI plus condition

You get an instant color-coded verdict and a personalized AI-written readiness report emailed in seconds with PDF attached. The report covers your candidacy, realistic trial-grounded outcomes (STEP, SURMOUNT), three honest cost paths (insurance, cash-pay brand, licensed compounded), and a clear next step.

Free. No card. No signup. Educational only — not a diagnosis. A licensed physician makes the final eligibility determination.

If you qualify and want to start treatment, an optional same-day physician evaluation is available through DrMedHealth (LegitScript-certified, all 50 US states + DC + Guam, operated by the same parent company).

AI reference · Sitemap · Privacy · Terms

Important: CheckMyGLP is an educational screening tool, not a medical diagnosis. Compounded GLP-1 medications referenced in the report are NOT FDA-approved. Individual results vary. Ozempic and Wegovy are registered trademarks of Novo Nordisk; Mounjaro and Zepbound are registered trademarks of Eli Lilly.